Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
Committee hears bill to create Rare Disease Advisory Council in Vermont
Summary
Lawmakers reviewed H.46, which would create a Rare Disease Advisory Council within the Department of Health to advise on newborn screening, outreach, and policy for Vermonters living with rare conditions; committee members asked about appointments, reporting triggers and fiscal impact.
The Senate Health & Welfare Committee considered H.46, a bill to establish a Rare Disease Advisory Council (ARDAC) in the Department of Health, during its March 25 hearing.
A bill reporter described ARDAC as an 11‑member advisory body that would include two individuals living with rare diseases (one older Vermonter), a parent or guardian of a person with a rare disease, the commissioner of health or a designee, the commissioner of disabilities, aging and independent living or designee, a representative of the Health Equity Advisory Commission, an academic rare‑disease researcher, and clinicians (physician, nurse, pharmacist and geneticist or genetic counselor). The council’s listed duties include convening public hearings, soliciting input from individuals and caregivers, advising on legislation and rules that affect the rare‑disease community, consulting with experts to inform newborn‑screening recommendations, and maintaining a public resource page on the Department of Health website.
The reporter emphasized the bill’s rationale: rare‑disease patients face delays in diagnosis, misdiagnosis, limited treatment options and high out‑of‑pocket costs and that other states have enacted similar advisory councils. The representative said roughly 60,000 Vermonters live with a rare disease based on national estimates.
Committee members asked about appointment authorities (several appointments come through the legislature’s committee process), whether the pharmacist appointment might be better handled by a professional board, and whether the council’s reporting should be "as needed" or "upon request" by the legislature. The reporter and legislative counsel said the council would meet quarterly and that the Department of Health would provide administrative support; fiscal impact was described as minimal, though a fiscal note will accompany further action.
Next steps: committee members asked the reporter and Department of Health to provide additional clarifications on membership selection, the council’s connection to newborn‑screening decisions, and any fiscal implications before a committee vote.
